Janz Jay M, Farrens David L
Department of Biochemistry and Molecular Biology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
J Biol Chem. 2004 Dec 31;279(53):55886-94. doi: 10.1074/jbc.M408766200. Epub 2004 Oct 8.
Little is known about the molecular mechanism of Schiff base hydrolysis in rhodopsin. We report here our investigation into this process focusing on the role of amino acids involved in a hydrogen bond network around the retinal Schiff base. We find conservative mutations in this network (T94I, E113Q, S186A, E181Q, Y192F, and Y268F) increase the activation energy (E(a)) and abolish the concave Arrhenius plot normally seen for Schiff base hydrolysis in dark state rhodopsin. Interestingly, two mutants (T94I and E113Q) show dramatically faster rates of Schiff base hydrolysis in dark state rhodopsin, yet slower hydrolysis rates in the active MII form. We find deuterium affects the hydrolysis process in wild-type rhodopsin, exhibiting a specific isotope effect of approximately 2.5, and proton inventory studies indicate that multiple proton transfer events occur during the process of Schiff base hydrolysis for both dark state and MII forms. Taken together, our study demonstrates the importance of the retinal hydrogen bond network both in maintaining Schiff base integrity in dark state rhodopsin, as well as in catalyzing the hydrolysis and release of retinal from the MII form. Finally, we note that the dramatic alteration of Schiff base stability caused by mutation T94I may play a causative role in congenital night blindness as has been suggested by the Oprian and Garriga laboratories.
关于视紫红质中席夫碱水解的分子机制,人们了解甚少。我们在此报告我们对这一过程的研究,重点关注参与视网膜席夫碱周围氢键网络的氨基酸的作用。我们发现该网络中的保守突变(T94I、E113Q、S186A、E181Q、Y192F和Y268F)增加了活化能(E(a)),并消除了在暗态视紫红质中席夫碱水解通常可见的凹形阿仑尼乌斯图。有趣的是,两个突变体(T94I和E113Q)在暗态视紫红质中显示出显著更快的席夫碱水解速率,但在活性MII形式中水解速率较慢。我们发现氘影响野生型视紫红质中的水解过程,表现出约2.5的特定同位素效应,并且质子存量研究表明,在暗态和MII形式的席夫碱水解过程中都发生了多个质子转移事件。综上所述,我们的研究证明了视网膜氢键网络在维持暗态视紫红质中席夫碱完整性以及催化MII形式中视网膜的水解和释放方面的重要性。最后,我们注意到突变T94I引起的席夫碱稳定性的显著改变可能在先天性夜盲症中起致病作用,奥普里安和加里加实验室已提出这一点。